浸润性乳腺癌报告指南:ICCR、CAP、RCPath、RCPA 数据集和未来方向

Natthawadee Laokulrath, Mihir Ananta Gudi, Rahul Deb, Ian O Ellis, Puay Hoon Tan
{"title":"浸润性乳腺癌报告指南:ICCR、CAP、RCPath、RCPA 数据集和未来方向","authors":"Natthawadee Laokulrath,&nbsp;Mihir Ananta Gudi,&nbsp;Rahul Deb,&nbsp;Ian O Ellis,&nbsp;Puay Hoon Tan","doi":"10.1016/j.mpdhp.2023.11.001","DOIUrl":null,"url":null,"abstract":"<div><p>Pathological characteristics are essential for breast cancer staging and treatment; hence, regional and country-based pathology reporting protocols have been produced to facilitate comprehensive reporting by pathologists<span>. However, these guidelines can vary in reporting variables, terminology definition, methods of measurement/scoring, which may lead to discordant information for clinicians and disagreement among pathologists. To obviate this, the International Collaboration on Cancer Reporting (ICCR) has recently produced datasets for histological reporting of breast cancer to unify the reporting elements, facilitating international comparability. In this review, we focus on the invasive breast carcinoma reporting datasets with the aim of providing an overview of ICCR recommendations in comparison with those published by regional professional organizations (the Royal College of Pathologists of the United Kingdom (UK) (RCPath), the United States (US) College of American Pathologists (CAP), the Royal College of Pathologists of Australasia (RCPA)), including relevant evidence with practical tips on accurate reporting of breast cancer resection specimens. In addition, we discuss some divergent aspects and suggest future directions for a unified breast cancer pathology reporting framework.</span></p></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"30 2","pages":"Pages 87-99"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Invasive breast cancer reporting guidelines: ICCR, CAP, RCPath, RCPA datasets and future directions\",\"authors\":\"Natthawadee Laokulrath,&nbsp;Mihir Ananta Gudi,&nbsp;Rahul Deb,&nbsp;Ian O Ellis,&nbsp;Puay Hoon Tan\",\"doi\":\"10.1016/j.mpdhp.2023.11.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Pathological characteristics are essential for breast cancer staging and treatment; hence, regional and country-based pathology reporting protocols have been produced to facilitate comprehensive reporting by pathologists<span>. However, these guidelines can vary in reporting variables, terminology definition, methods of measurement/scoring, which may lead to discordant information for clinicians and disagreement among pathologists. To obviate this, the International Collaboration on Cancer Reporting (ICCR) has recently produced datasets for histological reporting of breast cancer to unify the reporting elements, facilitating international comparability. In this review, we focus on the invasive breast carcinoma reporting datasets with the aim of providing an overview of ICCR recommendations in comparison with those published by regional professional organizations (the Royal College of Pathologists of the United Kingdom (UK) (RCPath), the United States (US) College of American Pathologists (CAP), the Royal College of Pathologists of Australasia (RCPA)), including relevant evidence with practical tips on accurate reporting of breast cancer resection specimens. In addition, we discuss some divergent aspects and suggest future directions for a unified breast cancer pathology reporting framework.</span></p></div>\",\"PeriodicalId\":39961,\"journal\":{\"name\":\"Diagnostic Histopathology\",\"volume\":\"30 2\",\"pages\":\"Pages 87-99\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diagnostic Histopathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1756231723001822\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic Histopathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756231723001822","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

病理特征对于乳腺癌的分期和治疗至关重要;因此,以地区和国家为基础的病理报告规程已经制定出来,以方便病理学家进行全面报告。然而,这些指南在报告变量、术语定义、测量/评分方法等方面存在差异,可能导致临床医生获得的信息不一致,病理学家之间也会产生分歧。为了避免这种情况,国际癌症报告合作组织(ICCR)最近制作了乳腺癌组织学报告数据集,以统一报告要素,促进国际间的可比性。在本综述中,我们将重点放在浸润性乳腺癌报告数据集上,目的是概述 ICCR 建议与地区性专业组织(英国皇家病理学家学院 (RCPath)、美国病理学家学院 (CAP)、澳大拉西亚皇家病理学家学院 (RCPA))发布的建议的比较,包括准确报告乳腺癌切除标本的相关证据和实用技巧。此外,我们还讨论了一些分歧,并提出了统一乳腺癌病理报告框架的未来发展方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Invasive breast cancer reporting guidelines: ICCR, CAP, RCPath, RCPA datasets and future directions

Pathological characteristics are essential for breast cancer staging and treatment; hence, regional and country-based pathology reporting protocols have been produced to facilitate comprehensive reporting by pathologists. However, these guidelines can vary in reporting variables, terminology definition, methods of measurement/scoring, which may lead to discordant information for clinicians and disagreement among pathologists. To obviate this, the International Collaboration on Cancer Reporting (ICCR) has recently produced datasets for histological reporting of breast cancer to unify the reporting elements, facilitating international comparability. In this review, we focus on the invasive breast carcinoma reporting datasets with the aim of providing an overview of ICCR recommendations in comparison with those published by regional professional organizations (the Royal College of Pathologists of the United Kingdom (UK) (RCPath), the United States (US) College of American Pathologists (CAP), the Royal College of Pathologists of Australasia (RCPA)), including relevant evidence with practical tips on accurate reporting of breast cancer resection specimens. In addition, we discuss some divergent aspects and suggest future directions for a unified breast cancer pathology reporting framework.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diagnostic Histopathology
Diagnostic Histopathology Medicine-Pathology and Forensic Medicine
CiteScore
1.30
自引率
0.00%
发文量
64
期刊介绍: This monthly review journal aims to provide the practising diagnostic pathologist and trainee pathologist with up-to-date reviews on histopathology and cytology and related technical advances. Each issue contains invited articles on a variety of topics from experts in the field and includes a mini-symposium exploring one subject in greater depth. Articles consist of system-based, disease-based reviews and advances in technology. They update the readers on day-to-day diagnostic work and keep them informed of important new developments. An additional feature is the short section devoted to hypotheses; these have been refereed. There is also a correspondence section.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信